⌘K
t
ECO Animal Health Group plc submitted a Block Listing Return on 05 March 2026 regarding its Executive Share Option Scheme and Unapproved Share Option Scheme, which originally listed 1,500,000 ordinary shares on 20 July 2017. For the period from 12 August 2025 to 12 February 2026, no securities were issued/allotted under the schemes, leaving a balance of 375,505 unallotted shares.
| Date | 5 Mar 2026 |
| Time | 16:19:38 |
| Category | Miscellaneous |
| ID | 5617V |
05 March 2026
ECO Animal Health Group plc
("ECO" or the "Company")
Block Listing Return
ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, today makes the following notification pursuant to Schedule Six of the AIM Rules for Companies regarding its existing block admission arrangements:
|
Name of applicant: |
ECO Animal Health Group plc |
|||
|
Name of scheme: |
Executive Share Option Scheme and Unapproved Share Option Scheme |
|||
|
Number and class of securities originally listed and the date of admission: |
1,500,000 ordinary shares of 5 pence each on 20 July 2017 |
|||
|
Period of return: |
From: |
12 August 2025 |
To: |
12 February 2026 |
|
Balance of unallotted securities under scheme(s) from previous return: |
375,505 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
0 |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period: |
0 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
375,505 |
|||
|
|
|
|
|
|
-Ends-
Contacts
|
ECO Animal Health Group plc David Hallas (Chief Executive Officer) Christopher Wilks (Chief Financial Officer)
|
020 8447 8899 |
|
ICR Healthcare (Financial PR) Mary-Jane Elliott Jessica Hodgson
|
020 3709 5700
|
|
Singer Capital Markets (Nominated Adviser & Joint Broker) Philip Davies Jalini Kalaravy Samed Ethemi
|
020 7496 3000 |
|
Panmure Liberum (Joint Broker) Emma Earl Will Goode Mark Rogers Rupert Dearden
|
020 3100 2000 |
|
Equity Development Hannah Crowe Matt Evans |
020 7065 2692 |
About ECO Animal Health
ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.
Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.
Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.
Click here for more information: https://ecoanimalhealth.com